1. The Order of the Government of the Russian Federation of August 28, 2014 No. 871 “About approval of Rules of forming of lists of medicines for medical application and the minimum range of the medicines necessary for delivery of health care.”
2. Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the economic evaluation of health care programmes (4th ed.). Oxford University Press.
3. Methodological recommendations on economic evaluations of pharmaceuticals, new edition No 242-oд of 29 December 2018 (2018). https://rosmedex.ru/wp-content/uploads/2019/06/MR-KE%60I_novaya-redaktsiya_2018-g..pdf. Accessed 30 Apr 2020.
4. Whitehead, S. J., & Ali, S. (2010). Health outcomes in economic evaluation: The QALY and utilities. British Medical Bulletin, 96(1), 5–21.
5. Khabibullina, A., & Gerry, C. J. (2019). Valuing health states in Russia: A first feasibility study. Value in Health Regional Issues, 19, 75–80.